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Background: In Lazio region (Italy), mortality data are currently available from the death
cause registry (DCR), which reports only underlying causes. Mortality due to other causes,
defined concurrent mortality, are need to appropriately estimate the health impact from
chronic diseases.
The aims of the study were to estimate concurrent mortality from chronic obstructive
pulmonary disease (COPD), using hospital discharge registry (HDR), to discuss the validity
and limits of this method, and to compare underlying and concurrent mortality from COPD
in the Lazio region.
Methods: A mortality study was carried out for residents who died in 1996–2000 with
COPD listed as the underlying cause of death and those who died in the hospital with a
different underlying cause of death listed but with a discharge diagnosis of COPD. Age-
standardized mortality rates were obtained for males and females separately, using the
direct method. A random sample of death certificates was used to validate concurrent
causes of death as defined from discharge diagnoses.
Results: Age-standardised mortality for COPD as underlying cause of death was 3.68/
10,000 in male and 2.29/10,000 in female residents. Mortality increased slightly in the
study period for women, but no trend was evident. Age-standardised mortality for COPD as
concurrent cause of death was 2.39/10,000 in male and 1.31/10,000 in female residents.
The positive predictive value for concurrent COPD mortality was 54.3%.
Conclusions: Concurrent COPD mortality contributed 62.3% to the whole mortality. The
estimates of concurrent COPD mortality were comparable to those reported in other
countries, though using hospital data may overestimate the real concurrent mortality as
estimated from death certificates.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Underlying and concurrent mortality for COPD 1989Introduction
Describing cause-specific mortality from chronic disease in
terms of a single underlying cause of death, was determined
to be inappropriate in 1986. Therefore, it was suggested
that analyses of mortality based on underlying causes of
death be complemented with multiple cause-of-death
statistics, where the other causes of death listed on the
death certificate could be considered.1
The need for indicators of impact and quality of care for
chronic diseases adds relevance to this approach. The World
Health Organisation (WHO) classified chronic obstructive
pulmonary disease (COPD) as the fifth cause of death
worldwide in 1999 and predicted it would rise to third by
2020.2 It has been estimated that COPD as concurrent cause
of death contributes 56.7% to the whole burden of mortality
in the United States of America (USA)3 and contributes 43.8%
to the whole burden of mortality in the United Kingdom.4 To
monitor COPD rates in the European Union, indicators for
COPD mortality include both underlying and contributing
causes of death.5
Multiple cause-of-death data have been produced routi-
nely in the USA since 1978, based on all causes reported in
death certificates.1 and in the UK all causes of death have
been listed electronically since 1993.4 In countries where
these data are not available, like in Italy, identifying
multiple causes of death requires carrying out specific
surveys or combining different data sources.
The aims of this paper are to estimate the number of
deaths to which COPD was a concurrent cause in the Lazio
region of Italy between 1996 and 2000, using an indirect
method based on hospital discharge diagnoses, to discuss
the validity and limits of this method; to compare COPD
mortality as underlying cause with COPD mortality as
concurrent cause of death.Study population and methods
Data to estimate COPD mortality as underlying cause of
death were obtained from the regional death cause registry
(DCR) that lists underlying causes of death for residents of
Lazio, regardless of place of death. Data to estimate COPD
mortality as a concurrent cause were obtained from hospital
discharge registry (HDR) of the Lazio region (Italy) that
reports the patient’s vital status at discharge and lists up to
four discharge diagnoses. The codes of the International
Classification of Diseases 9th version (ICD-9) such as 490.X,
491.X, 492.X, 494.X and 496.X were used to define COPD as
cause of death or discharge diagnosis, according to the
European protocol.5
Residents of the region, who died between 1996 and 2000
were included in the study if COPD was reported in the DCR
as the underlying cause of death, coding according to ICD-9;
we considered COPD as a concurrent cause of death for
subjects who died in the hospital, who had a different cause
of death registered in the DCR and an ICD-9 code for COPD
listed in the HDR as at least one of the four discharge
diagnoses. Information about residence was obtained in
both cases, from the DCR. Data of concurrent causes were
obtained through a record-linkage between the DCR and
HDR using SAS programme version 8; we only includedhospitalised patients for which death and discharge dates in
DCR and in HDR, respectively, corresponded.
The Lazio resident population in the period 1996–2000
taken from the National Institute of Vital Statistics was used
as the denominator. Specific rates for sex and age were
analysed for both underlying and concurrent causes of
death. Age-standardized mortality rates were obtained for
males and females separately, using the direct method and
the mean Italian population in 1996–2000 as the referent
population. Trends of both underlying and concurrent
mortality were compared; the test for trend was done by
linear regression with STATA (version 8).
The ratio of concurrent rate over underlying cause-of-
death rate per 1001 was used to analyse the relationship
between the two cause-of-death definitions of COPD
mortality as well as the frequencies with which leading
causes of death occur when COPD has not been listed as
underlying cause.4
A random sample of death certificates was used to
validate concurrent causes of death as defined from
discharge diagnoses. Death certificates were manually
searched for 12% of deaths with concurrent COPD and for
persons who had resided in Rome; the sample was stratified
for sex and age. The positive predicted value of hospital
registries with respect to death certificates was calculated
as the proportion of patients with a COPD reported in the
death certificate over all the concurrent causes of death
estimated from the diagnoses listed on HDR. Moreover, the
distributions of sex, age, and residence (city of Rome versus
towns and villages), were compared between all patients
who died from COPD as underlying cause, and the subgroup
of those who died in the hospital, to verify possible
systematic differences in using only hospitalised patients
to estimate concurrent mortality.Results
Mortality for COPD as underlying cause of death
There were 7005 deaths due to COPD as underlying cause or
5.6% of all deaths in the Lazio region in the period
1996–2000. Mortality was 2.68/10,000 inhabitants; rates
were higher for men (3.40/10,000) than for women (2.00/
10,000) with a gender ratio of 1.7. Notably, the rates
increased five or six times by each 10-year age group
starting from 35–44 to 65–74 years, both in males and in
females; above age 74 the rates were only three times
higher in men and four times higher in women compared to
the preceding age group (Table 1A). Mortality rates for COPD
as underlying cause of death in the period 1996–2000 did not
show any statistically significant trend for males (test
for trend, p-value ¼ 0.9) or for females (test for trend,
p-value ¼ 0.3).
Age-standardized mortality rates were higher than crude
rates for both men (3.68/10,000) and women (2.29/10,000),
as the Italian population is older and presents higher
proportions of people 70-year old and older, compared with
the regional population. The sex ratio favoured men (1.6),
and no trend was appreciable (p-value ¼ 0.8 for males and
p-value ¼ 0.3 for females) though the age-adjusted rates
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There were 4358 people who died with COPD defined as a
concurrent cause of death in the period 1996–2000 and
mortality was 1.67/10,000. The rates were higher for men
(2.22/10,000) than for women (1.15/10,000) with a gender
ratio of 1.9. Concurrent COPD mortality rates increased with
age (Table 1B) but did not show a trend (test for trend,
p-value ¼ 0.4 in males and p-value ¼ 0.3 in females).
The age-standardized rates for concurrent mortality were
2.39/10,000 for men and 1.31/10,000 for women, higher
estimates than the crude rates and a gender ratio in favour
of men (1.8). The rates increased slightly from 1996 to 2000
in both sexes but no trend was observed (test for trend,
p-value ¼ 0.5 in males and p-value ¼ 0.4 in females) (Fig. 1)
as for underlying COPD mortality. The leading causes of
death that reported COPD as concurrent were heart diseases
(40.3%), tumours (18.5%), cerebro-vascular diseases (10.6%)
and diseases of respiratory system excluding COPD (6.9%)
(Table 2).0.0
1996 1997 1998 1999 2000
a
Underlying Male Concurrent Male
Underlying Female Concurrent Female
Figure 1 Mortality due to COPD as underlying and concurrent
cause, by sex and year. Lazio, 1996–2000.Relationship between underlying and concurrent
causes of death for COPD
The concurrent/underlying mortality ratio of age-adjusted
rates was 62.3%. It was higher among males (65.3%) thanTable 1 Mortality rates for COPD as underlying and concurren
Age groups Male deaths
N Population Rate/10,000 95% CI
(A) Underlying cause
o15 0 1935352 0
15–24 2 1655134 0.01 0.001 0
25–34 2 2123710 0.01 0.001 0
35–44 9 1920883 0.05 0.021 0
45–54 41 1706341 0.24 0.17 0
55–64 217 1532839 1.42 1.23 1
65–74 1024 1144702 8.95 8.41 9
75–84 1708 490835 34.80 33.17 36
85+ 1289 123684 104.22 98.63 110
Total 4292 12633480 3.40 3.30 3
(B) Concurrent cause
o15 2 1935352 0.01 0.001 0
15–24 1 1655134 0.01 0.0002 0
25–34 2 2123710 0.01 0.001 0
35–44 3 1920883 0.02 0.003 0
45–54 21 1706341 0.12 0.08 0
55–64 161 1532839 1.05 0.89 1
65–74 748 1144702 6.53 6.08 7
75–84 1168 490835 23.80 22.45 25
85+ 694 123684 56.11 52.02 60
Total 2800 12633480 2.22 2.14 2among females (57.5%), and presented the highest value in
young–adult from 45 to 74 years of age. The concurrent/
underlying mortality ratio increased from 1996 to 2000 in
both sexes (Fig. 2).Validation of COPD hospital diagnosis as concurrent
cause of death
A sample of 280 death certificates was used to validate our
estimates among the 2426 deaths defined as concurrent
COPD causes of death that occurred in residents of Rome.
The positive predictive value (PPV) of concurrent COPDt cause. Lazio, 1996–2000.
Female deaths
N Population Rate/10,000 95% CI
0 1833475 0
.04 1 1587749 0.01 0.0002 0.04
.03 2 2137607 0.01 0.001 0.03
.09 3 1965900 0.02 0.003 0.04
.33 16 1798668 0.09 0.05 0.14
.62 75 1689323 0.44 0.35 0.56
.51 404 1436226 2.81 2.55 3.10
.49 938 808045 11.61 10.88 12.38
.03 1274 290607 43.84 41.47 46.31
.50 2713 13547600 2.00 1.93 2.08
.04 2 1833475 0.01 0.001 0.04
.03 0 1587749 0
.03 1 2137607 0.005 0.0001 0.03
.05 3 1965900 0.02 0.003 0.05
.19 12 1798668 0.07 0.03 0.12
.23 48 1689323 0.28 0.21 0.38
.02 258 1436226 1.80 1.58 2.03
.20 559 808045 6.92 6.36 7.52
.43 675 290607 23.23 21.51 25.05
.30 1558 13547600 1.15 1.09 1.21
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Table 2 Underlying causes of death in patients who
died in hospital with COPD reported as discharge
diagnosis but not as underlying cause of death. Lazio,
1996–2000.
Death cause Deaths
N %
All 4358 100
Respiratory diseases 301 6.91
TB 28 0.64
Asthma 17 0.39
Respiratory failure 47 1.08
Bronchopneumonia 85 1.95
Pneumoconiosis 9 0.21
Others 2.64
Tumors 807 18.52
Trachea, bronchus, lungs 287 6.59
Others 520 11.93
Diabetes 116 2.66
Heart diseases 1754 40.25
Ami 213 4.89
Other forms of ischemic heart diseases 524 12.02
Heart failure 176 4.04
Pulmonary embolism and cor pulmonale 63 1.45
Hypertension 231 5.30
Arrhythmias 100 2.29
Other heart diseases 447 10.26
Cerebral-vascular diseases 463 10.62
Digestive system disease 248 5.69
Genital-urinary system 92 2.11
Renal failure 74 1.70
Others 18 0.41
Not well defined 73 1.68
Fractures and concussions 135 3.10
Poisoningy 16 0.37
Other diseases 350 8.03
Infectious disease aftermaths 2 0.05
Bacterial or viral infections 18 0.41
Metabolic disorders other than diabetes 28 0.64
Anaemia and other blood diseases 20 0.46
Psychiatric diseases 55 1.26
CNS diseases 59 1.35
PNS diseases 5 0.11
Other vascular diseases 137 3.14
Decubitus ulcers 4 0.09
Bone and joint diseases 18 0.41
Congenital diseases 4 0.09
Not reported 3 0.07
TB ¼ tuberculosis, CNS ¼ central nervous system, PNS ¼ per-
ipheral nervous system.
Including arteriosclerosis, aneurysms, thrombo-embo-
lisms.
yIncluding side effects of drugs or therapeutic procedures’
effects.
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Figure 2 Ratio of concurrent over underlying COPD adjusted
mortality in males and females by year. Lazio, 1996–2000.
Underlying and concurrent mortality for COPD 1991mortality as estimated from hospital diagnoses compared
with that estimated from death certificates was 54.3%. The
value was 76.4% when respiratory failures reported on death
certificates were analysed as proxy diagnoses of COPD.When all underlying cause COPDs were compared with the
subgroup who died in the hospital, differences were
observed in age, sex and residence distributions. There
were fewer males and patients over 85 (4% and 9%,
respectively) among those who died in the hospital than
among all those who died from COPD. Finally, patients who
resided in Rome were more likely to die in the hospital (+4%)
than those who resided outside Rome.Discussion
Mortality for COPD as underlying cause of death
Mortality due to COPD is lower in the Lazio region for males
(3.68/10,000) than in Italy (4.02/10,000),6 while it is higher
(2.29 versus 2.00 per 10,000 ) for females.6 Mortality rates
observed in our region are lower than those reported in the
USA, where estimates range between 7.9 and 8.3 per 10,000
males and between 4.7 and 5.7 per 10,000 females in the
period 1996–20007; they are also lower than those reported
in England and Wales, where estimates range between 12.3
and 11.7 for males and 5.7 and 6.1 for females in 1996–1999.
Mortality rates did not present an increasing trend in our
region from 1996 to 2000, following what was observed in
rest of Italy.6 Nevertheless, the rate at which mortality
increased from 1996 to 2000 was higher in females (13.2%)
than in males (2.0%).
The increase in mortality for COPD at 35+ years of age was
observed as reported in other studies3,4; however in some
European countries8 mortality increased only in patients 54+
year old. Differences in coding COPD prevent us from
comparing age specific mortality rates in the Lazio region
with those in Italy; the national mortality6 in fact, includes
asthma (ICD-9 code 493.0), a disease that causes the highest
rates in patients under 35, while COPD show the highest
rates in patients over 34.3,4
The regional and national gender ratio (1.6 and 2.0,
respectively) that favours males suggests that work-related
exposures and smoking are still prevalent among males in
the Lazio region as well as in Italy. Nevertheless, the
regional mortality rates for females were higher than
national rates, suggesting that the impact of smoking on
men and women has been inverted at the regional level.
These results have to be confirmed by observations longer
than the 5 years studied here, but the inversion of smoking
exposure has been previously described in the USA.7
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whole burden of mortality
The rate at which the mortality for COPD increased from
1996 to 2000 was much higher for concurrent causes (29.9%
in males, 47.8% in females) than for underlying causes (2.0%
in males and 13.2% in females) suggesting that the
propensity to code COPD as a concurrent cause became
more frequent during the study period. On the other hand,
both the underlying and the concurrent mortality increased
allowing to conclude that the increase in mortality for COPD
is real although no trend was observed, and it cannot be
ascribed to codifying modifications of death causes.3
A different propensity in coding COPD as underlying cause
of death could help explain the differences in mortality
rates between different countries and different periods.
Mortality rates for underlying COPD in our region were lower
than those reported in the USA and also lower than those
reported in England and Wales. At the same time,
concurrent/underlying COPD ratio is 62.3% in our study,
much higher in USA (130%) and much lower (42.0% in males
and 37.5% in females) in England.4 Therefore, it is possible
that in USA COPD is codified more often as concurrent cause
and in England as underlying cause of death than in Lazio.
Both national comparisons and trend analyses would benefit
from using a multiple cause-of-death approach, as it allows
mortality estimates to be compared apart from geographical
differences and time modifications in codifying the under-
lying causes of death.
Cardiovascular diseases, tumours, cerebro-vascular dis-
eases and other respiratory diseases were the major
underlying causes of death where COPD was reported as
discharge diagnosis but not as underlying cause of death.
The findings are broadly in agreement with those from a UK
study4 and a study from Tucson, Arizona,9 but we found a
higher frequency of cerebro-vascular disease than found in
Britain (1.7%). Another study including seven European
countries10 reported the same general groups of diseases,
but the highest frequency was found for other respiratory
diseases, especially chronic respiratory failure (38%), and
heart failure (13%) while malignancy was third. The
observation that the most frequent causes of death other
than COPD are so similar in different countries allows us to
hypothesise that very similar clinical criteria justify attri-
buting a death cause other than COPD in patients ill with
COPD.Limits of the study
Based on the sex and age distribution of the concurrent/
underlying COPD ratio, we could conclude that in our region
there is a higher propensity to codify COPD as concurrent in
young–adult patients (45–74 years) than in those over 74
years both in males and in females. Unfortunately, these
conclusions are heavily influenced by differences in sex and
in age observed between the population of hospitalised
patients we used as the source of concurrent causes. We
found fewer very old patients than expected among
concurrent COPD deaths. This fact could be explained by
the use of hospital discharge records. In fact, comparing
those who died in the hospital with all patients who diedwith an underlying cause of COPD we found that the
older the patients were, the less likely they were to be
hospitalised.
Another limit in using the HDR as the source of concurrent
causes of death is that the concurrent/underlying cause
ratio has been estimated in similar but non-equal popula-
tions, the former being estimated only in hospitalised
patients and the latter among all deaths. This prevents us
from estimating a cumulative multiple cause of death rate.
The original ratio proposed by Israel et al.1 uses the
frequency with which a cause of death is reported on the
death certificate, compared with the frequency the cause is
selected as the underlying cause of death in the same
population.
Finally, we obtained a PPV of concurrent COPD mortality
estimated from hospital diagnoses as low as 54.3%, which
means we detected among the concurrent causes of COPD
almost 45.7% of deaths for which COPD had not been
reported on the death certificate. Therefore, our method
compared to the death certificates may have over-esti-
mated concurrent mortality. Adding respiratory failure
allowed us to get a PPV of 76.4%, but this approach would
require changing the definition of COPD as concurrent cause
of death.
Conclusions
An additional 62.3% of COPD mortality as concurrent cause
must be added to COPD mortality as underlying cause in our
region, to correctly determine the whole burden of COPD
mortality. Moreover, the multiple cause-of-death approach
assures more valid national comparisons of COPD mortality
as it takes into account geographical differences and time
variations in codifying causes of deaths.
The method we present to estimate concurrent mortality
using the discharge diagnoses registry gets estimate very
close to those reported in other countries and assures a good
reproducibility over time, although it may overestimate the
real concurrent mortality as estimated from death certifi-
cates and may cause a negative selection of males and very
old patients. Further applications of this method could help
to identify its potential and its limits.
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